From Med City News. "A Bristol Myers Squibb drug whose landmark FDA approval introduced the first novel mechanism for treating schizophrenia in decades| Mad In America
A recent randomized controlled trial explores the effectiveness of low-dose ketamine (LDK) as an adjunct to morphine in emergency settings.| St.Emlyn's
The RADAR trial is complete. Disappointingly it showed that people who gradually reduce their antipsychotic medication are more likely to relapse than people who continue it. At 2-year follow-up th…| Joanna Moncrieff